ARS Pharmaceuticals, Inc (SPRY)

ARS Pharmaceuticals, Inc (SPRY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $427M; returns 1 day -6.7%, 1 week +0.2%, 1 year -58.2%.

ARS Pharmaceuticals Inc., trading under the ticker SPRY, is a commercial-stage biopharmaceutical company focused on developing and commercializing needle-free, self-administered treatments for severe allergic reactions.

Groups SPRY belongs to

• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Unmet Medical Needs

SPRY financial model: income statement, cash flow and balance sheet